InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,868.40
(
-0.79%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
86.99
(
-0.27%
)
Bitcoin
64,253.96
(
-0.04%
)
Post# of 53906
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Tuff-Stuff

Send PM Follow Ignore
Followers 219
Posts 247348
Boards Moderated 2
Alias Born 04/06/2006

Tuff-Stuff

Re: None

Friday, 01/02/2015 8:52:36 AM

Friday, January 02, 2015 8:52:36 AM

Post# of 53906
Regulus Therapeutics (NASDAQ:RGLS) is up 8% premarket on modest volume. Shares have retraced 38% from the high of $25.60 on November 10. In late October, prices ballooned almost 4-fold in response to its report of positive results for RG-101 in patients with HCV.

Pray for A Pain Free Day!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up